Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.46 |
| ▸ | FABP3 | P05413 | 7/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28422160 | 1.00 | FABP3 (0.49) | FABP3CA1DGKAGPR84CES2 | |
| SCHEMBL28422152 | 1.00 | FABP3 (0.49) | FABP3CA1DGKAGPR84CES2 | |
| SCHEMBL3469474 | 1.00 | FABP3 (0.49) | FABP3CA1DGKAGPR84CES2 | |
| SCHEMBL3773636 | 0.90 | DGKA (0.53) | DGKAGPR84CES2CES1LMNA | |
| Dodecanoic Anhydride SCHEMBL18166491 | 0.86 | CA1 (0.61) | FABP3CA1DGKACES2CES1 | |
| SCHEMBL29078967 | 0.84 | CA1 (0.54) | FABP3CA1DGKAGPR84CES2 | |
| SCHEMBL15735322 | 0.84 | CA1 (0.54) | FABP3CA1DGKAGPR84CES2 | |
| SCHEMBL29203845 | 0.84 | CA1 (0.46) | FABP3CA1DGKAGPR84CES2 | |
| SCHEMBL3773638 | 0.83 | GPR84 (0.53) | FABP3GPR84LMNA | |
| SCHEMBL5274080 | 0.83 | DGKA (0.50) | DGKACES2CES1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109072128-B | Detergent composition and process for producing the same | 旭化成精细化工股份有限公司 | 2020-07-10 | — | — | CN | disclosed |
| US-8513174-B2 | Cleanser | SHISEIDO COMPANY LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| EP-2251403-B1 | CLEANSING COMPOSITION | SHISEIDO CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20100317555-A1 | Cleanser | SHISEIDO COMPANY LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| EP-2251403-A1 | CLEANSING COMPOSITION | Shiseido Company, Ltd. (JP) | 2010-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317555-A1 | Cleanser | STS, SGMS1, PTDSS1 | CA1 822/4885FABP3 2724/4885DGKA 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.